Solid Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Solid Biosciences

13/08/2024 23:11

* Solid Biosciences Inc  SLDB.OQ  reported a quarterly
adjusted
loss of 61 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $-1.25.  The mean expectation of eight analysts
for the quarter was for a loss of 66 cents per share. Wall
Street expected results to range from -72 cents to -61 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Solid Biosciences Inc's reported EPS for the quarter was a
loss
of 61 cents​.
    * The company reported a quarterly loss of $25.07 million.
    * Solid Biosciences Inc shares had risen by 26.3% this
quarter and
gained 16.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Solid Biosciences
Inc is $18.00 
This summary was machine generated from LSEG data August 13 at
10:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.66          -0.61          Beat
 Mar. 31 2024      -0.64          -0.64          Met
 Dec. 31 2023      -0.99          -1.00          Missed
 Sep. 30 2023      -1.19          -1.05          Beat